Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults

NCT01228383 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Crucell Holland BV